Skip to main content

September 2016

 

 

academics

 

Clinical research courses

Vacancy for Executive - Operation(HBP) in Apollo Hospitals

Apollo Hospitals is the forerunner of integrated healthcare in Asia, as well as globally. The group's futuristic vision has ensured that it has been in a position of strength at every touch point of the healthcare delivery chain. Its presence encompasses across 56 hospitals, more than 2300 pharmacies, over 100 primary care & diagnostic clinics, 115 telemedicine units across 9 countries, health insurance services, global projects consultancy, 15 academic institutions and a Research Foundation with a focus on global clinical trials, epidemiological studies, stem-cell and genetic research.
Over the past three decades Apollo Hospitals' transformative journey has forged a legacy of excellence in Indian healthcare.

Post: Executive - Operation(HBP)- 1 post

Walk-in-interview for engagement of Project Assistants( 20 posts) under CSIR Network Scheme at CIMAP

Central Institute of Medicinal and Aromatic Plants, popularly known as CIMAP, is a frontier plant research laboratory of Council of Scientific and Industrial Research (CSIR). Established originally as Central Indian Medicinal Plants Organisation (CIMPO) in 1959, CIMAP is steering multidisciplinary high quality research in biological and chemical sciences and extending technologies and services to the farmers and entrepreneurs of medicinal and aromatic plants (MAPs) with its research headquarter at Lucknow and Research Centres at Bangalore, Hyderabad, Pantnagar and Purara.

Eligible and interested candidates may attend the Interview for engagement on purely temporary basis as Project Assistants of different level/JRF/RA-Projects on contract basis in the Projects under CSIR Network Scheme, Grant-in-aid Projects and other projects sponsored by Govt. Agencies tenable at CSIR-CIMAP, Lucknow in various disciplines detailed as under:

Walk in Interview at Lupin Pharma for Officer / Executive - B.Pharm, M.Pharm, B.Sc

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.

Lupin Limited is one of India’s leading pharma company with presence in markets across the globe, invites candidates for interview as per below details for their Indore Plant

Post : Officer / Executive

Applications are invited for Scientist ‘B’ ICMR Project in Division of ECD

Applications are invited for the following purely temporary post on consolidated salary in the Division of ECD, for a period of one year only in the project entitled, “Assessment of viral hepatitis burden in Northeast India: A systematic study”

Post : Scientist ‘B’ (Non Medical) (Gen)

Wanted Business Training Manager in Abbott

Abbott is about the power of health. For more than 125 years, Abbott has been helping people reach their potential — because better health allows people and communities to achieve more. With a diverse, global network serving customers in more than 150 countries, we create new solutions — across the spectrum of health, around the world, for all stages of life. Whether it’s next-generation diagnostics, life-changing devices, science-based nutrition, or novel reformulations, we are advancing some of the most innovative and revolutionary technologies in healthcare, helping people live their best lives through better health.

Post: Business Training Manager

Vacancy for Purchase Officer/ Executive in Client of Nurture Consultancy | 06 posts

We are hiring for Reputed Fine Chemical Company.

Post: Purchase Officer/ Executive

Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS cure.

Viamet Pharmaceuticals, Inc. announced that the US Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation to VT-1598, a novel candidate for the oral treatment of coccidioidomycosis, or valley fever. Valley fever is an invasive fungal infection found primarily in the southwest United States that affects an estimated 150,000 people annually.

The U.S. Food and Drug Administration (FDA) has approved Bayer AG’s new low dose levonorgestrel-releasing intrauterine system (LNG-IUS) which will be marketed in the US under the brand name Kyleena™. Kyleena releases the lowest daily dose of the hormone levonorgestrel in an intrauterine system for up to five years of effective protection against pregnancy, using the smallest T-shaped body in an IUS available today. Long-acting contraception is one of the most effective methods of birth control as it does not require user interventions such as daily dosing or monthly re-fills. An LNG-IUS can be removed at any time and offers rapid return to a woman’s natural level of fertility after removal.

(adsbygoogle = window.adsbygoogle || []).push({});

BioInvent International has been granted additional patent protection in Japan, Russia and China for BI-505, its lead immune-oncology programme currently in phase II for the treatment of multiple myeloma. These patents cover the use of BI-505 in the treatment of patients previously treated for cancer that have either not responded or subsequently relapsed. The patents now granted, add to patents previously granted in these countries, as well as in the US, Europe and other countries for BI-505 and its use in the treatment of cancer. BI-505 has received Orphan Drug designation for multiple myeloma by both the US Federal Drug Administration (FDA) and European Medicines Agency (EMA).